Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ejca.2021.01.003 | DOI Listing |
Publication Analysis
Top Keywords
letter response
4
response comments
4
comments on 'a
4
on 'a phase
4
phase dose-escalation
4
dose-escalation study
4
study oxaliplatin
4
oxaliplatin delivered
4
delivered laparoscopic
4
laparoscopic approach
4
Similar Publications
Response by Yamashita et al to Letter Regarding Article, "Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial)".
Circulation
September 2025
Department of Cardiology, Hirakata Kohsai Hospital, Hirakata, Japan (T.K.).
A Strategic Path Forward for Hospice and Palliative Care Must Focus on Equity: A Response to Byock.
Palliat Med Rep
August 2025
Division of Geriatrics, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
Clinical Relevance and Prognostic Value of the Triple A (AAA) Score in Patients With Myelofibrosis (MF) Treated With Ruxolitinib (RUX).
Eur J Haematol
September 2025
Hematology, Department of Translational and Precision Medicine, Policlinico Umberto I-Sapienza University, Rome, Italy.
Response to "Three-Cusp View Orientation in TAVI: LOA Versus Non-LOA-Translating Anatomical Alignment Into Functional Coronary Access".
Catheter Cardiovasc Interv
September 2025
Peshawar Institute of Cardiology, Peshawar, Pakistan.
Gammopathic dermopathies: A retrospective review of cutaneous response to haematologic therapy.
J Eur Acad Dermatol Venereol
September 2025
Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut, USA.